MYC and ovarian carcinoma: Furthermore, TBX3, a c‐Myc downstream target, has been implicated in the expansion of breast cancer stem cells (CSCs) as well as the self‐renewal and stemness of mesenchymal stromal/stem cells, ovarian cancer and PDAC CSCs [19, 27, 37].